Information  X 
Enter a valid email address

Assura plc (AGR)

  Print   

Thursday 12 May, 2022

Assura plc

Updated results presentation timing

RNS Number : 1781L
Assura PLC
12 May 2022
 

12 May 2022

Assura plc

Updated results presentation timing

Please note that the timing of the results presentation on Wednesday 18 May 2022 has changed from our previous announcement.

Assura plc ("the Company"), the UK's leading primary care property investor and developer will announce Annual Results for the year ended 31 March 2022 on Wednesday 18 May 2022.

A presentation for analysts and investors, immediately followed by a live Q&A with members of the senior management team can be viewed at 11.00 am BST at the following link:

https://webcasting.brrmedia.co.uk/broadcast/625e82ca841dd838fd0be3a3

Presentation via the Investor Meet Company platform

Separately, Jonathan Murphy (CEO) and Jayne Cottam (CFO) will host a live presentation relating to the Annual Results for the year ended 31 March 2022 via the Investor Meet Company platform on Thursday 9 June 2022 at 11.30 am BST.

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9.00 am the day before the meeting or at any time during the live presentation. 

Investors can sign up to Investor Meet Company for free and register to follow Assura plc via this link: https://www.investormeetcompany.com/assura-plc/register-investor

Investors who already follow Assura plc on the Investor Meet Company platform will automatically be invited to the event.

- Ends -

 

For more information, please contact:

Assura plc
David Purcell, Investor Relations Director

Tel: 01925 945354
E mail: [email protected]

Finsbury Glover Hering

Gordon Simpson
James Thompson

Tel: 0207 251 3801
Email: [email protected]

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2021, Assura's portfolio was valued at £2,595 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORQFLFFLELEBBE

a d v e r t i s e m e n t